Harvard Bioscience (HBIO) Net Cash Flow (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Net Cash Flow of -$1.3 million for Q1 2026, down 217.47% year-over-year from $1.1 million in Q1 2025, and down 173.6% quarter-over-quarter from $1.8 million in Q4 2025.
Harvard Bioscience (HBIO) Net Cash Flow (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Net Cash Flow for 17 consecutive years, with -$1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 217.47% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at $1.2 million (up 25.93% YoY), while the FY2025 annual figure was $3.6 million, up 10314.29% from the prior year.
- Net Cash Flow declined to -$1.3 million in Q1 2026 per HBIO's latest filing, from $1.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $1.8 million in Q4 2025 and bottomed at -$2.4 million in Q1 2022.
- Historically, Net Cash Flow has averaged -$54764.7 across 5 years, with a median of -$98000.0 in 2024.
- On a YoY basis, Net Cash Flow climbed as much as 1889.8% in 2025 and fell as far as 458.94% in 2025.
- Harvard Bioscience's Net Cash Flow stood at -$286000.0 in 2022, then slumped by 205.59% to -$874000.0 in 2023, then jumped by 88.79% to -$98000.0 in 2024, then soared by 1889.8% to $1.8 million in 2025, then sank by 173.6% to -$1.3 million in 2026.
- Business Quant data shows HBIO's Net Cash Flow at -$1.3 million in Q1 2026, $1.8 million in Q4 2025, and -$542000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 746.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -42.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -192.18 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 95.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -160.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 17.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 149.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -629,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -629,000.00 |
| Jun 30, 2026 | -629,000.00 |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | -542,000.00 |
| Sep 30, 2025 | -542,000.00 |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -98,000.00 |
| Dec 31, 2024 | -98,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | -211,000.00 |
| Jun 30, 2024 | -211,000.00 |
| Mar 31, 2024 | 123,000.00 |
| Mar 31, 2024 | 123,000.00 |